Page last updated: 2024-11-04

sumatriptan and Glaucoma, Angle Closure

sumatriptan has been researched along with Glaucoma, Angle Closure in 3 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Zormpas, S2
Matsou, A2
Antunes, DM2
Panos, C2
Hsu, CR1
Chen, YH1
Tai, MC1
Lu, DW1

Other Studies

3 other studies available for sumatriptan and Glaucoma, Angle Closure

ArticleYear
Sumatriptan dose increase-induced acute angle closure glaucoma in chronic migraine sufferer.
    Drug and therapeutics bulletin, 2022, Volume: 60, Issue:8

    Topics: Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Migraine Disorders; Sumatriptan

2022
Sumatriptan dose increase-induced acute angle closure glaucoma in chronic migraine sufferer.
    BMJ case reports, 2021, Feb-23, Volume: 14, Issue:2

    Topics: Acute Disease; Female; Glaucoma, Angle-Closure; Humans; Middle Aged; Migraine Disorders; Sumatriptan

2021
Sumatriptan-induced angle-closure glaucoma: A case report.
    Medicine, 2017, Volume: 96, Issue:22

    Topics: Adult; Diagnosis, Differential; Female; Glaucoma, Angle-Closure; Humans; Migraine Disorders; Sumatri

2017